Literature DB >> 22995056

[Use of magnesium sulfate in obstetrics].

G Kayem1, L Mandelbrot, B Haddad.   

Abstract

Magnesium sulfate (MgSO(4)) is the best treatment of eclampsia, reduces the risk of recurrence better than other anticonvulsants and is recommended as first line in cases of eclampsia. In cases of severe pre-eclampsia and especially when prodromes are present, MgSO(4) reduces better than conventional anticonvulsants the risk of eclampsia. More recently, MgSO(4) was used in cases of preterm delivery to reduce the risk of cerebral palsy in premature infants. Three large randomized trials have obtained convergent results which all tended to show a neuroprotective effect of MgSO(4). These trials were included in three meta-analyzes that showed a 30% reduction in the incidence of cerebral palsy before 32 weeks gestation suggesting that this drug should be used in cases of preterm birth. A protocol using low doses associated with a well-conducted maternal surveillance reduces of maternal hypermagnesemia and the risk of maternal toxicity.
Copyright © 2012. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995056     DOI: 10.1016/j.gyobfe.2012.08.005

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  2 in total

Review 1.  Multivariate Analysis and Machine Learning in Cerebral Palsy Research.

Authors:  Jing Zhang
Journal:  Front Neurol       Date:  2017-12-21       Impact factor: 4.003

2.  In vitro and in vivo responses of macrophages to magnesium-doped titanium.

Authors:  Bin Li; Huiliang Cao; Yaochao Zhao; Mengqi Cheng; Hui Qin; Tao Cheng; Yan Hu; Xianlong Zhang; Xuanyong Liu
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.